Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis

World Journal of Gastroenterology

Volumn 20, Issue 13, 2014, Pages 3590-3596

  Kim, Tae Kyoung ^a   Jang, Hyun Jung ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Contrast ultrasound; Dysplastic nodule; Hepatocellular carcinoma; Imaging; Liver cirrhosis

Indexed keywords

ECHO CONTRAST MEDIUM; PERFLUBUTANE; CONTRAST MEDIUM;

ABLATION THERAPY; BILE DUCT CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED ECHOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SURVEILLANCE; ECHOGRAPHY; FOLLOW UP; HEMANGIOMA; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER PARENCHYMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; RADIOFREQUENCY ABLATION; REVIEW; VEIN THROMBOSIS; CHEMISTRY; IMAGE ENHANCEMENT; LIVER TUMOR; MICROBUBBLE; PROCEDURES;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICROBUBBLES; VENOUS THROMBOSIS;

EID: 84897487376     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i13.3590     Document Type: Review

References (23)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
2. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474 [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7]
3. European Association For The Study Of The Liver1; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438]
4. Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57: 930-932 [PMID: 22739095 DOI: 10.1016/j.jhep.2012.04.018]
5. Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: what role? Radiology 2010; 257: 24-39 [PMID: 20851938 DOI: 10.1148/radiol.10091210]
6. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 2008; 190: 691-695 [PMID: 18287440 DOI: 10.2214/AJR.07.3116]
7. Wilson SR, Kim TK, Jang HJ, Burns PN. Enhancement patterns of focal liver masses: discordance between contrastenhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 2007; 189: W7-W12 [PMID: 17579140 DOI: 10.2214/AJR.06.1060]
8. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 2008; 190: 58-66 [PMID: 18094294 DOI: 10.2214/AJR.07.2493]
9. Bhayana D, Kim TK, Jang HJ, Burns PN, Wilson SR. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am J Roentgenol 2010; 194: 977-983 [PMID: 20308500 DOI: 10.2214/AJR.09.3375]
10. Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR. Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 2007; 26: 1703-1714 [PMID: 18029922]
11. Jang HJ, Kim TK, Wilson SR. Imaging of malignant liver masses: characterization and detection. Ultrasound Q 2006; 22: 19-29 [PMID: 16641790]
12. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906 [PMID: 17709836 DOI: 10.1148/radiol. 2443061520]
13. Jang HJ, Kim TK, Wilson SR. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol 2009; 72: 418-424 [PMID: 18834687 DOI: 10.1016/j.ejrad.2008.08.011]
14. Takahashi M, Maruyama H, Shimada T, Kamezaki H, Sekimoto T, Kanai F, Yokosuka O. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 2013; 82: 75-84 [PMID: 23116806 DOI: 10.1016/j.ejrad.2012.05.035]
15. Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O. Contrast-enhanced ultrasound for characterization of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. Br J Radiol 2012; 85: 351-357 [PMID: 21224305 DOI: 10.1259/bjr/20440141]
16. Sugimoto K, Moriyasu F, Shiraishi J, Saito K, Taira J, Saguchi T, Imai Y. Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging. Eur Radiol 2012; 22: 1205-1213 [PMID: 22270142 DOI: 10.1007/s00330-011-2372-3]
17. Kim TK, Lee KH, Khalili K, Jang HJ. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging 2011; 36: 244-263 [PMID: 21253723 DOI: 10.1007/ s00261-011-9686-0]
18. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430 [PMID: 11592607 DOI: 10.1016/S0168-8278(01)00130-1]
19. Khalili K, Kim TK, Jang HJ, Yazdi LK, Guindi M, Sherman M. Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none? Hepatology 2011; 54: 2048-2054 [PMID: 22057624 DOI: 10.1002/hep.24638]
20. Kim TK, Lee KH, Jang HJ, Haider MA, Jacks LM, Menezes RJ, Park SH, Yazdi L, Sherman M, Khalili K. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 2011; 259: 730-738 [PMID: 21364083 DOI: 10.1148/radiol.11101549]
21. Kim TK, Jang HJ, Wilson SR. Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q 2006; 22:31-39 [PMID: 16641791]
22. Kim YJ, Lee MW, Park HS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom Imaging 2013; 38: 98-111 [PMID: 22467060 DOI: 10.1007/s00261-012-9883-5]
23. Raza SA, Jang HJ, Kim TK. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging 2014; 39: 153-161 [PMID: 24002440 DOI: 10.1007/s00261-013-0034-4]